While our past efforts have focused on defining the domains and motifs that constitute the building blocks for AKAP targeting of PKA, our focus now has shifted to understanding how large macromolecular signaling scaffolds are assembled. Our multi-scale approaches are allowing us not only to achieve a mechanistic understanding of such scaffolds at atomic level resolution but also to understand the cellular architecture of PKA scaffolds that are assembled at the mitochondria and how these scaffolds change in response to cAMP and as a function of diet and disease. We are focusing, in particular, on the uniqueness of the PKA isoforms as revealed by newly solved structures of full-length holoenzymes and on a newly discovered and highly conserved mitochondrial PKA substrate, ChChdS, that is localized to the intermembrane space. ChchdS nucleates a large scaffold that bridges the inner and outer membranes and plays a major role in crista biogenesis [1]. Also recruited to this complex is a novel Rl-specific AKAP, Sphingosine Kinase Interacting Protein (SKIP), recently discovered by Scott and Taylor [2, 3]. Depletion of ChchdS leads to loss of crista and loss of oxidative metabolism while ChchdS is enriched in livers of mice fed on a high fat diet (HFD), which is associated with insulin resistance and obesity, hallmark symptoms of Type II diabetes. We will use the expertise of the Analytical Core (Core A) to define the molecular features of these complexes while the Multi-Scale Ceil Imaging Core (Core B) will be used to define the architecture of the mitochondria and how it changes dynamically in response to cAMP and to diet and depletion of ChchdS. In parallel, we are using miniSOG (small Singlet Oxygen Generator) techno-logy, recently discovered by Tsien and Ellisman [4] to finely map localized sites of PKA signaling. MinSOG, a genetically encoded tag that generates singlet oxygen that can then be used for EM contrast, has the potential to do for EM what GFP did for fluorescence microscopy. Moving from atomic level resolution to defining the dynamic molecular architecture of organelles is the driving motivation for Protect I as we try to understand how specificity in PKA signaling is achieved through dynamic and polyvalent signaling scaffolds. Our specific goals are as follows.
In Aim I we will crystallize an Rl-specific AKAP bound to full-length Rip, an isoform that is enriched in mitochondria.
In Aim II we define the molecular and dynamic features of ChChdS using peptide arrays, structural biology, and mass spectrometry, in Aim III we use miniSOG reporters to define PKA targeting sites and to correlate PKA signaling with mitochondria dynamics.
In Aim I V we will collaborate with Olefsky to elucidate tissue-specific changes in PKA signaling and mitochondria morphology in response to a HFD.

Public Health Relevance

Although PKA plays a major role in regulating metabolism and mitochondrial dynamics, we lack knowledge of how macromolecular signaling scaffolds target specific PKA isoforms to mitochondria and how they are regulated. The multi scale strategy outlined here will define structural and cellular PKA scaffolds at the mitochondria and elucidate how these scaffolds and mitochondrial dynamics change in response to diet induced insulin resistance and obesity, hallmarks of type II diabetes. Novel targets for intervention will likely emerge as well as enhanced molecular understanding of biological signaling by PKA.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-6 (J1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
La Jolla
United States
Zip Code
Baeza-Raja, Bernat; Sachs, Benjamin D; Li, Pingping et al. (2016) p75 Neurotrophin Receptor Regulates Energy Balance in Obesity. Cell Rep 14:255-68
Cherry, Allison E; Haas, Brian R; Naydenov, Alipi V et al. (2016) ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme. Mol Cancer Ther 15:2018-29
Turnham, Rigney E; Scott, John D (2016) Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology. Gene 577:101-8
Nygren, Patrick J; Scott, John D (2016) Regulation of the phosphatase PP2B by protein-protein interactions. Biochem Soc Trans 44:1313-1319
Bjerregaard-Andersen, Kaare; Østensen, Ellen; Scott, John D et al. (2016) Malonate in the nucleotide-binding site traps human AKAP18γ/δ in a novel conformational state. Acta Crystallogr F Struct Biol Commun 72:591-7
Whiting, Jennifer L; Ogier, Leah; Forbush, Katherine A et al. (2016) AKAP220 manages apical actin networks that coordinate aquaporin-2 location and renal water reabsorption. Proc Natl Acad Sci U S A 113:E4328-37
Nieves-Cintrón, Madeline; Hirenallur-Shanthappa, Dinesh; Nygren, Patrick J et al. (2016) AKAP150 participates in calcineurin/NFAT activation during the down-regulation of voltage-gated K(+) currents in ventricular myocytes following myocardial infarction. Cell Signal 28:733-40
Kountz, Timothy S; Lee, Kyung-Soon; Aggarwal-Howarth, Stacey et al. (2016) Endogenous N-terminal Domain Cleavage Modulates α1D-Adrenergic Receptor Pharmacodynamics. J Biol Chem 291:18210-21
Cordes, Thekla; Wallace, Martina; Michelucci, Alessandro et al. (2016) Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels. J Biol Chem 291:14274-84
Riggle, Kevin M; Riehle, Kimberly J; Kenerson, Heidi L et al. (2016) Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma. Pediatr Res 80:110-8

Showing the most recent 10 out of 202 publications